SUBSTITUTED INDOLIZINES AND DERIVATIVES AS CNS AGENTS
申请人:Wyeth
公开号:EP1807427A2
公开(公告)日:2007-07-18
US7608626B2
申请人:——
公开号:US7608626B2
公开(公告)日:2009-10-27
[EN] SUBSTITUTED INDOLIZINES AND DERIVATIVES AS CNS AGENTS<br/>[FR] INDOLIZINES SUBSTITUEES ET DERIVES UTILISES COMME AGENTS DU SYSTEME NERVEUX CENTRAL
申请人:WYETH CORP
公开号:WO2006050007A2
公开(公告)日:2006-05-11
[EN] Compounds of formula (I) of pharmaceutically acceptable salts thereof are provided: formula (I), which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of central nervous system disorders such as schizophrenia. [FR] L'invention porte sur des composés de formule (I) ou sur leurs sels acceptables d'un point de vue pharmaceutique, ces composés étant des agonistes ou des agonistes partiels du sous-type 2C des récepteurs de la sérotonine du cerveau. Les composés et les compositions contenant les composés peuvent être utilisés pour traiter différents troubles du système nerveux central tels que la schizophrénie.
Substituted indolizines and derivatives as CNS agents
申请人:Sabb Louise Annmarie
公开号:US20060094752A1
公开(公告)日:2006-05-04
Compounds of formula 1 or pharmaceutically acceptable salts thereof are provided:
which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of central nervous system disorders such as schizophrenia.